Reserve Inotropes for Select Cases of Acute or End-Stage Heart Failure
September 2019
Do the IV inotropes dobutamine and milrinone still have a role in treating heart failure with reduced ejection fraction (HFrEF)?
Yes...but only in a small subset of patients.
Both meds increase arrhythmias. And widespread use fell out of favor years ago...due to concerns about increased mortality, especially in patients withOUT low cardiac output and hypotension.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote